0001628280-24-001690.txt : 20240118
0001628280-24-001690.hdr.sgml : 20240118
20240118163815
ACCESSION NUMBER: 0001628280-24-001690
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240116
FILED AS OF DATE: 20240118
DATE AS OF CHANGE: 20240118
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Christensen Jamie
CENTRAL INDEX KEY: 0001599324
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35921
FILM NUMBER: 24542327
MAIL ADDRESS:
STREET 1: C/O MIRATI THERAPEUTICS, INC.
STREET 2: 9393 TOWNE CENTRE DRIVE, SUITE 200
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Mirati Therapeutics, Inc.
CENTRAL INDEX KEY: 0001576263
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 462693615
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3545 CRAY COURT
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 858-332-3410
MAIL ADDRESS:
STREET 1: 3545 CRAY COURT
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
4
1
wk-form4_1705613883.xml
FORM 4
X0508
4
2024-01-16
0
0001576263
Mirati Therapeutics, Inc.
MRTX
0001599324
Christensen Jamie
C/O MIRATI THERAPEUTICS, INC.
3545 CRAY COURT
SAN DIEGO
CA
92121
0
1
0
0
EVP & Chief Scientific Officer
0
Common Stock
2024-01-16
4
S
0
966
59.02
D
156558
D
Common Stock
2024-01-16
4
S
0
631
59.02
D
155927
D
Represents shares sold by the Company to satisfy the tax withholding obligation associated with
the vesting of a portion of the restricted stock units (RSUs) granted on January 14, 2022.
Includes 347 shares acquired under the ESPP Purchase on 05/31/2023 and 42 shares acquired under the ESPP purchase on 11/30/2023.
Represents shares sold by the Company to satisfy the tax withholding obligation associated with
the vesting of a portion of the restricted stock units (RSUs) granted on January 15, 2021.
/s/ John Moriarty, Attorney-in-Fact
2024-01-18